Literature DB >> 12468964

Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy.

Daniel Helbling1, Thomas H Breitbach, Martin Krause.   

Abstract

This case report describes a 63-year-old woman with a 15-year history of Crohn's disease. After a severe relapse with colitis she was treated with immunosuppressive agents, including an increased dosage of corticosteroids, azathioprine and a single dose of infliximab (anti-tumour necrosis factor-alpha). This led to a brief improvement, which was followed by worsening diarrhoea, fever and skin lesions. Biopsies from upper and lower endoscopies and from an ulcerative skin lesion revealed cytomegalovirus vasculitis in all the tissues removed. The patient improved slowly by withdrawal of the immunosuppressives and with anti-viral therapy. Whenever patients with inflammatory bowel disease deteriorate rapidly, cytomegalovirus infection should be ruled out before the immunosuppressive therapy is fortified.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468964     DOI: 10.1097/00042737-200212000-00018

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  21 in total

Review 1.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

2.  Cytomegalovirus colitis in children with inflammatory bowel disease.

Authors:  B Ghidini; M Bellaiche; D Berrebi; J Viala; J P Hugot; J F Mougenot; A Munck; M Peuchmaur; J P Cezard
Journal:  Gut       Date:  2006-04       Impact factor: 23.059

Review 3.  Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature.

Authors:  Joel W Alderson; Thomas G Van Dinter; Michael J Opatowsky; Elizabeth C Burton
Journal:  MedGenMed       Date:  2005-09-21

4.  Cytomegalovirus colitis in a patient with Behcet's disease receiving tumor necrosis factor alpha inhibitory treatment.

Authors:  Ismail Sari; Merih Birlik; Can Gonen; Servet Akar; Duygu Gurel; Fatos Onen; Nurullah Akkoc
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

5.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis.

Authors:  Gulbu Uzel; Jordan S Orange; Nina Poliak; Beatriz E Marciano; Theo Heller; Steven M Holland
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

Review 6.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

7.  Massive splenomegaly due to concurrent primary Epstein-Barr virus and cytomegalovirus infection in a patient on adalimumab.

Authors:  Barathy Rani Ramasamy; Patrick Charles; Douglas Johnson; Albert Frauman
Journal:  BMJ Case Rep       Date:  2017-09-01

8.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 9.  Biologic treatments for systemic rheumatic diseases.

Authors:  Y Shirota; G G Illei; N P Nikolov
Journal:  Oral Dis       Date:  2008-02-14       Impact factor: 3.511

10.  Maintenance of cytomegalovirus-specific CD4pos T-cell response in rheumatoid arthritis patients receiving anti-tumor necrosis factor treatments.

Authors:  Jean-Luc Davignon; Jean-Frédéric Boyer; Bénédicte Jamard; Delphine Nigon; Arnaud Constantin; Alain Cantagrel
Journal:  Arthritis Res Ther       Date:  2010-07-15       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.